| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |